Jonathan Phillip Greenberg , MBBCH
Ophthalmology • Wayne, NJ
1044 Route 23 Ste 208
Wayne, NJ 074706685
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on July 13, 2015; this date does not establish years in practice.
-
Published CMS data list 24,371 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2777 — Injection, faricimab-svoa, 0.1 mg: 8,640 service units.
- J0177 — Injection, aflibercept hd, 1 mg: 4,864 service units.
- J2781 — Injection, pegcetacoplan, intravitreal, 1 mg: 2,250 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 19 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 583 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Prednisolone Acetate — 237 prescription fills, including refills.
- Ketorolac Tromethamine — 146 prescription fills, including refills.
- Ofloxacin — 45 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 12 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Wayne, NJ (2024, 13 clinicians with data). Median for this group: 1,498. Middle half: 1,020 to 3,195.
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in New Jersey (2024, 442 clinicians with data). Median for this group: 2,291. Middle half: 1,055 to 4,088.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 109 in 2020 to 24,371 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
1044 Route 23 Ste 208
Wayne, NJ 074706685
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Associated Retinal Consultants Llc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2008
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
788 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $3,974,778 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $3,140,858 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
809 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$25,482 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $303.06 across 18 records.
By nature of payment
- Food and Beverage: $303.06 across 18 records.
Reporting-company totals (3 largest of 8)
- Astellas Pharma US Inc: $87.83 across 5 records.
- Regeneron Pharmaceuticals, Inc.: $49.44 across 3 records.
- ANI Pharmaceuticals, Inc.: $45.76 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
18 years (graduated 2008)
CMS Doctors and Clinicians data list 2008 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2015
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Jonathan Greenberg has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Jonathan Greenberg as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Wayne and New Jersey
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Wayne, NJ (2024, 13 clinicians with data). Median for this group: 1,498. Middle half: 1,020 to 3,195.
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in New Jersey (2024, 442 clinicians with data). Median for this group: 2,291. Middle half: 1,055 to 4,088.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Ophthalmology in Wayne, NJ (2024, 13 clinicians with data). Median for this group: $194,840. Middle half: $98,946 to $423,333.
A higher Medicare-allowed amount than 95% of clinicians listed under Ophthalmology in New Jersey (2024, 442 clinicians with data). Median for this group: $257,081. Middle half: $109,308 to $470,056.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Ophthalmology in Wayne, NJ (2024, 13 clinicians with data). Median for this group: $151,006. Middle half: $72,638 to $324,729.
A higher Medicare payment amount than 95% of clinicians listed under Ophthalmology in New Jersey (2024, 442 clinicians with data). Median for this group: $184,083. Middle half: $79,904 to $344,335.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Ophthalmology in Wayne, NJ (2024, 12 clinicians with data). Median for this group: 533. Middle half: 376 to 971.
Fewer Part D prescriptions than 65% of clinicians listed under Ophthalmology in New Jersey (2024, 468 clinicians with data). Median for this group: 1,008. Middle half: 362 to 1,885.
Part D drug cost
A lower Part D drug cost than 80% of clinicians listed under Ophthalmology in Wayne, NJ (2024, 12 clinicians with data). Median for this group: $62,258. Middle half: $33,740 to $142,763.
A lower Part D drug cost than 75% of clinicians listed under Ophthalmology in New Jersey (2024, 468 clinicians with data). Median for this group: $141,459. Middle half: $28,136 to $307,554.
17 active clinicians are listed under Ophthalmology with a practice address in Wayne, NJ (631 in New Jersey).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Wayne
5.9% of these 17 clinicians have the CMS telehealth indicator.
88.2% of these 17 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 22259% from 109 in 2020 to 24,371 in 2024.
- 2020: 109
- 2021: 1,421
- 2022: 6,370
- 2023: 25,409
- 2024: 24,371
-
Medicare-allowed amount
Medicare-allowed amount increased 45100% from $8,794 in 2020 to $3,974,778 in 2024.
- 2020: $8,794
- 2021: $329,045
- 2022: $1,511,631
- 2023: $3,349,141
- 2024: $3,974,778
-
Paid by Medicare
Paid by Medicare increased 49969% from $6,273 in 2020 to $3,140,858 in 2024.
- 2020: $6,273
- 2021: $266,664
- 2022: $1,191,870
- 2023: $2,646,404
- 2024: $3,140,858
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 271% from 157 in 2020 to 583 in 2024.
- 2020: 157
- 2021: 70
- 2022: 245
- 2023: 394
- 2024: 583
-
30-day fills
30-day fills increased 298% from 203 in 2020 to 809 in 2024.
- 2020: 203
- 2021: 98
- 2022: 335
- 2023: 605
- 2024: 809
-
Part D drug cost
Part D drug cost increased 395% from $5,147 in 2020 to $25,482 in 2024.
- 2020: $5,147
- 2021: $2,282
- 2022: $15,689
- 2023: $23,675
- 2024: $25,482
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $381.81 in 2021 to $303.06 in 2025.
- 2021: $381.81
- 2022: $200.89
- 2023: $496.23
- 2024: $451.11
- 2025: $303.06
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 18 records totaling $303.06.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $20.00 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $18.84 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $18.75 |
| Oyster Point Pharma, Inc. |
Food and Beverage
In-kind items and services
|
TYRVAYA | General | $17.99 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
ILUVIEN | General | $17.84 |
| Apellis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Syfovre | General | $17.75 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
Cequa | General | $17.59 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $17.46 |
| Mallinckrodt Hospital Products Inc. |
Food and Beverage
In-kind items and services
|
ACTHAR | General | $17.27 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
OZURDEX | General | $17.14 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
Cequa | General | $16.76 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $16.26 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $16.10 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
OZURDEX | General | $15.53 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $15.52 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $14.34 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
YUTIQ | General | $14.23 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PURIFIED CORTROPHIN GEL | General | $13.69 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2018–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2019–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2777
Injection, faricimab-svoa, 0.1 mg
|
8,640 | 41 | $125.00 | $34.32 |
|
J0177
Injection, aflibercept hd, 1 mg
|
4,864 | 178 | $812.50 | $330.33 |
|
J2781
Injection, pegcetacoplan, intravitreal, 1 mg
|
2,250 | 32 | $366.67 | $146.58 |
|
92014
Established patient complete exam of visual system
|
1,960 | 700 | $366.00 | $143.41 |
|
92134
Imaging of retina
|
1,853 | 647 | $450.00 | $45.90 |
|
67028
Injection of drug into eye
|
1,407 | 326 | $583.96 | $135.86 |
|
92202
Extended exam of the back part of the eye with optic nerve drawing
|
1,245 | 527 | $115.00 | $17.19 |
|
Q5128
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
|
555 | 35 | $1000.00 | $230.23 |
|
J0178
Injection, aflibercept, 1 mg
|
452 | 76 | $2500.00 | $809.43 |
|
92250
Photography of the retina
|
234 | 200 | $194.00 | $40.98 |
|
J3590
Unclassified biologics
|
201 | 114 | $7405.47 | $2980.07 |
|
99426
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
|
161 | 36 | $165.00 | $70.11 |
|
92201
Extended exam of the back part of the eye with retinal drawing
|
135 | 98 | $125.00 | $27.61 |
|
92012
Established patient problem focused exam of visual system
|
105 | 71 | $259.00 | $102.25 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
81 | 81 | $470.00 | $188.51 |
|
76512
2d ultrasound scan of eye tissue and structures
|
78 | 62 | $263.00 | $53.92 |
|
J7999
Compounded drug, not otherwise classified
|
56 | 28 | $702.86 | $92.60 |
|
99427
Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month
|
55 | 30 | $128.00 | $53.76 |
|
92235
Exam of retinal blood vessels using a special camera after injection of a dye
|
39 | 37 | $373.00 | $190.72 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Prednisolone Acetate | Prednisolone Acetate | 237 | 6,922 | $9,015.62 | 104 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 146 | 4,405 | $4,817.54 | 50 |
| Ofloxacin | Ofloxacin | 45 | 1,048 | $603.98 | 40 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 27 | 2,415 | $387.33 | 14 |
| Brimonidine Tartrate | Brimonidine Tartrate | 20 | 1,443 | $411.31 | — |
| Atropine Sulfate | Atropine Sulfate | 20 | 806 | $477.47 | — |
| Difluprednate | Difluprednate | 20 | 560 | $2,164.38 | — |
| Latanoprost | Latanoprost | 15 | 829 | $248.25 | — |
| Timolol Maleate | Timolol Maleate | 14 | 810 | $56.18 | — |
| Bromfenac Sodium | Bromfenac Sodium | 14 | 591 | $4,673.37 | — |
| Dorzolamide Hcl | Dorzolamide Hcl | 13 | 956 | $188.52 | — |
| Simbrinza | Brinzolamide/Brimonidine Tart | 12 | 675 | $2,437.87 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-11-13NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20230427001063
PA
8628302247
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Associated Retinal Consultants Llc
1044 Rte, Wayne, NJ 074706631
Phone: 9736339898
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 1044 ROUTE 23 STE 208, WAYNE, NJ 074706685 (Tel: 9736339898)
Registered at 420 MOUNTAIN AVE FL 4, NEW PROVIDENCE, NJ 079742736 (Tel: 9084588333)
Ophthalmology (license number reported to NPPES: PA MD480594)
Registered at 925 N 87TH ST, MILWAUKEE, WI 532264812 (Tel: 4144562020)
Registered at 925 N 87TH ST, MILWAUKEE, WI 532264812 (Tel: 4144562020)
Ophthalmology (license number reported to NPPES: WI 71204)
NPI status registered as active in NPPES database
Registered at 555 ROCKAWAY PKWY, ROOM 134 CHC BUILDING, BROOKLYN, NY 112123132 (Tel: 7182406347)
Registered at 555 ROCKAWAY PKWY, ROOM 134 CHC BUILDING, BROOKLYN, NY 112123132 (Tel: 7182406347)
Recorded as JONATHAN GREENBERG, MBBCH
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Wayne
- Dr. Stephen Gollance, MD
- Dr. Subhashini Chandrasekaran, MD
- Dr. Nancy Choo, MD
- Dr. Deanna Macek, MD
- Joel Pakett
- Dr. Noreen Shaikh, MD
Mailing Address
420 Mountain Ave Fl 4
New Providence, NJ 079742736
Phone: 9084588333